Show simple item record

dc.contributor.authorHoare, Sarah
dc.contributor.authorPowell, Alison
dc.contributor.authorModi, Rakesh Narendra
dc.contributor.authorArmstrong, Natalie
dc.contributor.authorGriffin, Simon J
dc.contributor.authorMant, Jonathan
dc.contributor.authorBurt, Jenni
dc.contributor.authorSAFER Authorship Group
dc.date.accessioned2022-03-18T11:00:28Z
dc.date.available2022-03-18T11:00:28Z
dc.date.issued2022-03-16
dc.date.submitted2021-04-01
dc.identifier.issn2044-6055
dc.identifier.otherbmjopen-2021-051703
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/335157
dc.description.abstractOBJECTIVES: There is insufficient evidence to support national screening programmes for atrial fibrillation (AF). Nevertheless, some practitioners, policy-makers and special interest groups have encouraged introduction of opportunistic screening in primary care in order to reduce the incidence of stroke through earlier detection and treatment of AF. The attitudes of the public towards AF screening are unknown. We aimed to explore why AF screening participants took part in the screening. DESIGN: Semistructured longitudinal interview study of participant engagement in the SAFER study (Screening for Atrial Fibrillation with ECG to Reduce stroke). We undertook initial interviews face to face, with up to two follow-up telephone interviews during the screening process. We thematically analysed and synthesised these data to understand shared views of screening participation. SETTING: 5 primary care practices in the East of England, UK. PARTICIPANTS: 23 people taking part in the SAFER study first feasibility phase. RESULTS: Participants were supportive of screening for AF, explaining their participation in screening as a 'good thing to do'. Participants suggested screening could facilitate earlier diagnosis, more effective treatment, and a better future outcome, despite most being unfamiliar with AF. Participating in AF screening helped attenuate participants' concerns about stroke and demonstrated their commitment to self-care and being a 'good patient'. Participants felt that the screening test was non-invasive, and they were unlikely to have AF; they therefore considered engaging in AF screening was low risk, with few perceived harms. CONCLUSIONS: Participants assessed the SAFER AF screening programme to be a legitimate, relevant and safe screening opportunity, and complied obediently with what they perceived to be a recommendation to take part. Their unreserved acceptance of screening benefit and lack of awareness of potential harms suggests that uptake would be high but reinforces the importance of ensuring participants receive balanced information about AF screening initiatives. TRIAL REGISTRATION NUMBER: ISRCTN16939438; Pre-results.
dc.description.sponsorshipNational Institute for Health Research (NIHR) Programme Grants for Applied Research (grant reference number RP-PG-0217-20007) and School for Primary Care Research (SPCR-2014-10043, project 410). Health Foundation
dc.languageen
dc.publisherBMJ
dc.subjectPublic health
dc.subject1506
dc.subject1724
dc.subjectprimary care
dc.subjectcardiology
dc.subjectpublic health
dc.subjectqualitative research
dc.titleWhy do people take part in atrial fibrillation screening? Qualitative interview study in English primary care.
dc.typeArticle
dc.date.updated2022-03-18T11:00:28Z
prism.issueIdentifier3
prism.publicationNameBMJ Open
prism.volume12
dc.identifier.doi10.17863/CAM.82586
dcterms.dateAccepted2022-02-09
rioxxterms.versionofrecord10.1136/bmjopen-2021-051703
rioxxterms.versionVoR
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0/
rioxxterms.licenseref.startdate2022-03-15
dc.contributor.orcidHoare, Sarah [0000-0002-8933-217X]
dc.contributor.orcidPowell, Alison [0000-0003-2524-5357]
dc.contributor.orcidModi, Rakesh Narendra [0000-0001-9651-6690]
dc.contributor.orcidArmstrong, Natalie [0000-0003-4046-0119]
dc.contributor.orcidGriffin, Simon J [0000-0002-2157-4797]
dc.contributor.orcidMant, Jonathan [0000-0002-9531-0268]
dc.contributor.orcidBurt, Jenni [0000-0002-0037-274X]
dc.identifier.eissn2044-6055
pubs.funder-project-idNational Institute for Health Research (NIHR) (via Cambridgeshire and Peterborough Clinical Commissioning Group (CCG)) (PGfAR RP-PG-0217-20007)
cam.issuedOnline2022-03-16
rioxxterms.freetoread.startdate2022-03-15
rioxxterms.freetoread.startdate2022-03-15


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record